However, for the management of patients with relatively large hemangiomas, we can emphasize that the follow-up tumor size measurement using US as well as the evaluation of d-dimer, platelets, and other coagulation factors (PT, fibrinogen, TAT, and FDP) during the follow-up period are indicated. The gene discussed is F2; the disease is hemangioma.